Stryker Earnings Preview: What to Expect

Company Overview - Stryker Corporation, based in Portage, Michigan, is a leading global medical technology company specializing in orthopaedics, MedSurg, and neurotechnology solutions, with a market cap of $135.7 billion [1] Earnings Expectations - Analysts anticipate Stryker to report a fiscal fourth-quarter profit of $4.39 per share on a diluted basis, reflecting a 9.5% increase from $4.01 per share in the same quarter last year [2] - For the full fiscal year, EPS is expected to be $13.56, an 11.2% increase from $12.19 in fiscal 2024, with further growth projected to $14.98 in fiscal 2026, representing a 10.5% year-over-year rise [3] Stock Performance - Stryker's stock has declined by 4.3% over the past year, underperforming the S&P 500 Index's 14.8% gains and the Health Care Select Sector SPDR Fund's 11.8% rise during the same period [4] Analyst Ratings - The consensus opinion on Stryker's stock is bullish, with a "Strong Buy" rating from 18 out of 27 analysts, while two suggest a "Moderate Buy" and seven give a "Hold" rating [6] - The average analyst price target for Stryker is $432.88, indicating a potential upside of 22% from current levels [6] Recent Developments - On December 19, Stryker's shares rose over 1% following an upgrade by Citizens JMP Securities from "Market Perform" to "Outperform," with a price target set at $440, reflecting confidence in the company's long-term growth outlook [5]